BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21287612)

  • 21. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
    Hagemann IS; Narzinski KD; Floyd DH; Baranski TJ
    J Biol Chem; 2006 Dec; 281(48):36783-92. PubMed ID: 17023413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
    Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
    Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
    Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
    World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C5aR activation in the absence of C5a: A new disease mechanism of autoimmune hemolytic anemia in mice.
    Syed SN; Rau E; Ziegelmann M; Sogkas G; Brüne B; Schmidt RE
    Eur J Immunol; 2018 Apr; 48(4):696-704. PubMed ID: 29277896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cells.
    Nishiura H; Tokita K; Li Y; Harada K; Woodruff TM; Taylor SM; Nsiama TK; Nishino N; Yamamoto T
    Apoptosis; 2010 Aug; 15(8):966-81. PubMed ID: 20473571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.
    Schreiber A; Xiao H; Jennette JC; Schneider W; Luft FC; Kettritz R
    J Am Soc Nephrol; 2009 Feb; 20(2):289-98. PubMed ID: 19073822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.
    Christophe T; Rabiet MJ; Tardif M; Milcent MD; Boulay F
    J Biol Chem; 2000 Jan; 275(3):1656-64. PubMed ID: 10636859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
    Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
    Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
    Lee H; Whitfeld PL; Mackay CR
    Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning, expression, cellular distribution, and role in chemotaxis of a C5a receptor in rainbow trout: the first identification of a C5a receptor in a nonmammalian species.
    Boshra H; Li J; Peters R; Hansen J; Matlapudi A; Sunyer JO
    J Immunol; 2004 Apr; 172(7):4381-90. PubMed ID: 15034053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decoy nanoparticles bearing native C5a receptors as a new approach to inhibit complement-mediated neutrophil activation.
    Li Y; Lin F
    Acta Biomater; 2019 Nov; 99():330-338. PubMed ID: 31446047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
    Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
    Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning and characterization of rainbow trout (Oncorhynchus mykiss) C5a anaphylatoxin receptor.
    Fujiki K; Liu L; Sundick RS; Dixon B
    Immunogenetics; 2003 Dec; 55(9):640-6. PubMed ID: 14628104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer.
    Piao C; Zhang WM; Li TT; Zhang CC; Qiu S; Liu Y; Liu S; Jin M; Jia LX; Song WC; Du J
    Exp Cell Res; 2018 May; 366(2):127-138. PubMed ID: 29551360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
    Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
    Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.
    Yuan B; Fu F; Huang S; Lin C; Yang G; Ma K; Shi H; Yang Z
    Mol Neurobiol; 2017 Oct; 54(8):6187-6197. PubMed ID: 27709492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat.
    Daveau M; Benard M; Scotte M; Schouft MT; Hiron M; Francois A; Salier JP; Fontaine M
    J Immunol; 2004 Sep; 173(5):3418-24. PubMed ID: 15322206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-dependent C5a and C5aR expression in dental pulp cells following stimulation with LTA and LPS.
    Liu M; Mu H; Peng W; Zhao L; Hu W; Jiang Z; Gao L; Cao X; Li N; Han J
    Int J Mol Med; 2019 Sep; 44(3):823-834. PubMed ID: 31257457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis.
    Imamura T; Yamamoto-Ibusuki M; Sueta A; Kubo T; Irie A; Kikuchi K; Kariu T; Iwase H
    Breast Cancer; 2016 Nov; 23(6):876-885. PubMed ID: 26494574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
    Xu GL; Chen J; Yang F; Li GQ; Zheng LX; Wu YZ
    Hepatology; 2014 Jul; 60(1):114-24. PubMed ID: 24604562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.